NASDAQ:IRBT • US4627261005
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IROBOT CORP (IRBT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-14 | Needham | Reiterate | Hold -> Hold |
| 2025-03-13 | Needham | Reiterate | Hold -> Hold |
| 2025-01-21 | Needham | Reiterate | Hold -> Hold |
| 2024-11-07 | Needham | Reiterate | Hold |
| 2024-08-08 | Needham | Reiterate | Hold |
| 2024-03-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-07-27 | Citigroup | Maintains | Neutral -> Neutral |
| 2022-08-08 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2022-07-14 | Citigroup | Maintains | Neutral |
| 2022-05-06 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-12-22 | Citigroup | Maintains | Neutral |
| 2021-07-29 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-05-05 | Northland Capital Markets | Maintains | Market Perform |
| 2021-02-12 | Citigroup | Maintains | Neutral |
| 2021-02-08 | JP Morgan | Maintains | Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.183B -24.38% | 890.58M -24.74% | 681.849M -23.44% | 535.63M -21.44% | 907.32M 69.39% | |
| EBITDA YoY % growth | -173.8M -606.71% | -223.134M -28.39% | -47.376M 78.77% | 19.778M 141.75% | -18.956M -195.84% | |
| EBIT YoY % growth | -221.7M -22,270.00% | -255.925M -15.44% | -69.043M 73.02% | -91.93M -33.15% | -12.247M 86.68% | |
| Operating Margin | -18.73% | -28.74% | -10.13% | -17.16% | -1.35% | |
| EPS YoY % growth | -4.31 -431.54% | -7.73 -79.35% | -5.52 28.59% | -3.57 35.33% | -1.13 68.34% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.73 64.35% |
| Revenue Q2Q % growth | 163.2M -5.14% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -17.233M 66.49% |
All data in USD
IROBOT CORP (IRBT) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of IROBOT CORP (IRBT) is -0.73 USD and the consensus revenue estimate is 163.20M USD.